Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgan T Sutton

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Stem Cells International|August 15, 2014
Stem cells: innovations in clinical applicationsMorgan T Sutton, Tracey L Bonfield
Journal of Biomedical Materials Research. Part A|February 21, 2024
Polymerized cyclodextrin microparticles for sustained antibiotic delivery in lung infectionsTracey L Bonfield, Sean T Zuckerman, Morgan T Sutton, et al.
Frontiers in Pharmacology|May 31, 2021
Enhancing Cystic Fibrosis Immune RegulationAnna M van Heeckeren, Morgan T Sutton, David R Fletcher, et al.
Stem Cells Translational Medicine|May 4, 2021
Donor-defined mesenchymal stem cell antimicrobial potency against nontuberculous mycobacteriumTracey L Bonfield, Morgan T Sutton, David R Fletcher, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the "First in Cystic Fibrosis" Phase I Clinical Trial (CEASE-CF)Tracey L Bonfield, Morgan T Sutton, David R Fletcher, et al.
Plos One|December 12, 2017
Conjugation of nitrated acetaminophen to Der p1 amplifies peripheral blood monocyte response to Der p1Ryan G Thomas, Brenda M Rivera Reyes, Benjamin M Gaston, et al.
Journal of Stem Cell Research & Therapy|January 2, 2018
Mesenchymal Stem Cell Soluble Mediators and Cystic FibrosisMorgan T Sutton, David Fletcher, Nicole Episalla, et al.
Stem Cells International|March 1, 2016
Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and TreatmentMorgan T Sutton, David Fletcher, Santosh K Ghosh, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Stem Cells International|August 15, 2014
Stem cells: innovations in clinical applicationsMorgan T Sutton, Tracey L Bonfield
Journal of Biomedical Materials Research. Part A|February 21, 2024
Polymerized cyclodextrin microparticles for sustained antibiotic delivery in lung infectionsTracey L Bonfield, Sean T Zuckerman, Morgan T Sutton, et al.
Frontiers in Pharmacology|May 31, 2021
Enhancing Cystic Fibrosis Immune RegulationAnna M van Heeckeren, Morgan T Sutton, David R Fletcher, et al.
Stem Cells Translational Medicine|May 4, 2021
Donor-defined mesenchymal stem cell antimicrobial potency against nontuberculous mycobacteriumTracey L Bonfield, Morgan T Sutton, David R Fletcher, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the "First in Cystic Fibrosis" Phase I Clinical Trial (CEASE-CF)Tracey L Bonfield, Morgan T Sutton, David R Fletcher, et al.
Plos One|December 12, 2017
Conjugation of nitrated acetaminophen to Der p1 amplifies peripheral blood monocyte response to Der p1Ryan G Thomas, Brenda M Rivera Reyes, Benjamin M Gaston, et al.
Journal of Stem Cell Research & Therapy|January 2, 2018
Mesenchymal Stem Cell Soluble Mediators and Cystic FibrosisMorgan T Sutton, David Fletcher, Nicole Episalla, et al.
Stem Cells International|March 1, 2016
Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and TreatmentMorgan T Sutton, David Fletcher, Santosh K Ghosh, et al.
Pageof 1